{"title":"Device Therapy Recommendations In Recent Heart Failure Guidelines: A Closer Look","authors":"O. Baysan, İ. Akyıldız","doi":"10.24969/hvt.2022.318","DOIUrl":null,"url":null,"abstract":"Recent guidelines released by two sides of Atlantic (1, 2) provide a general roadmap for medical community dealing with heart failure management. In these guidelines heart failure patients are classified according to their ejection fraction (EF) values: Heart Failure with Preserved EF (HFpEF), Heart Failure with Mildly Reduced EF (HFmrEF) and Heart Failure with Reduced EF (HFrEF). Non-pharmacological and pharmacological treatment options are recommended in these guidelines in relevant sections pertaining to heart failure subgroups. Device therapy is mainly restricted to HFrEF patients due to clinical data obtained from this heart failure subgroup. We aimed to highlight two guideline’s similarities and differences in device therapy recommendations for a busy clinician.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Vessels and Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24969/hvt.2022.318","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Recent guidelines released by two sides of Atlantic (1, 2) provide a general roadmap for medical community dealing with heart failure management. In these guidelines heart failure patients are classified according to their ejection fraction (EF) values: Heart Failure with Preserved EF (HFpEF), Heart Failure with Mildly Reduced EF (HFmrEF) and Heart Failure with Reduced EF (HFrEF). Non-pharmacological and pharmacological treatment options are recommended in these guidelines in relevant sections pertaining to heart failure subgroups. Device therapy is mainly restricted to HFrEF patients due to clinical data obtained from this heart failure subgroup. We aimed to highlight two guideline’s similarities and differences in device therapy recommendations for a busy clinician.